# Benign Prostatic Hyperplasia

## Length of Authorizations

365 Days

## Prior Authorization Criteria

1.  Is there any reason the patient cannot be changed to a medication not requiring prior approval? Acceptable reasons include:
    1.  Allergy to medications not requiring prior approval
    2.  Contraindications to or drug interaction with medications not requiring prior approval
    3.  History of unacceptable/toxic side effects to medications not requiring prior approval
2.  Patient must have a therapeutic failure to no less than a **30-day** trial on at least **two** medications that are preferred.

## Additional Criteria for Approval Of Tadalafil (CIALIS)

Patient must have diagnosis of benign prostatic hyperplasia and have a therapeutic failure to no less than a 30-day trial on at least one alpha-1 adrenergic blocker and a 90-day trial of finasteride.

## Formulary

Genitourinary Agents: Benign Prostatic Hyperplasia

| PREFERRED             | NON-PREFERRED          |
|-----------------------|------------------------|
| Alfuzosin             | Cardura XL             |
| Doxazosin             | Dutasteride/Tamsulosin |
| Dutasteride           | Silodosin              |
| Finasteride           |                        |
| Prazosin              |                        |
| Tadalafil PA 2.5, 5mg |                        |
| Tamsulosin            |                        |
| Terazosin             |                        |

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=66)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220701_UPDL_FINAL.pdf#page=23)
